Listen in to this discussion on enhancing efficiency for cardiologists and care teams with an integrated imaging and patient data strategy. Enterprise imaging simplifies IT by consolidating multi-ology images with patient data and providing a single view of all patient information. 

If you’re looking to grow your CCTA program or start one, listen in. Learn from cardiology and radiology experts at Wellstar Health System who have built a successful CCTA program.

Listen in to this CEU webinar to gain a deeper understanding of how the technology of intravascular lithotripsy (IVL) works in order to code appropriately for peripheral and coronary IVL procedures. We dig into coding and billing specifics for hospitals, ambulatory surgery centers and physicians across all payor types. Make sure your team is aware of all the coding rules and updates for 2025. To get your CEU, take the quiz and download your certificate!

What are the benefits of accurately assessing plaque burden in your patients with suspected coronary artery disease (CAD)? Listen to two cardiologists discuss the advantages of using a coronary CTA pathway along with AI-based plaque analysis and physiology to understand a patient’s risks of cardiovascular events.

The Society of Cardiovascular Computed Tomography is cheering as a “huge win” the 2025 CMS payment increase for coronary CTA that more than doubles the current payment and “better aligns with the cost of providing CCTA services." The panel expects the move to bring an increase in CT utilization, more adoption with financial sustainability and greater access in currently underutilized areas.

Data standardization in medical imaging has evolved from a technical necessity to a strategic imperative, requiring an ontology-level approach to patient studies for optimization. According to Radiologist Cheryl Petersilge and CIO Matt Dewey, hospitals and imaging groups are increasingly implementing advanced standardization solutions. The benefits are significant, including greater radiologist efficiency, improved access to imaging exams, and increased accuracy in both human and AI-driven interpretations. 

Despite the use of effective drug and device therapies, many patients with HFrEF continue to experience worsening symptoms and disease progression. Barostim is a novel device therapy that works with drug therapies to target the neurohormonal pathways responsible for heart failure progression and symptoms. Patients feel better and their quality of life improves.

Lesion-specific physiology matters! Three leading experts review cases that demonstrate why and how lesion-specific physiology can inform treatment for patients with CAD and lessons learned from 10 years of FFR_CT interpretation.